Heterogeneous expression and functions of androgen receptor co-factors in primary prostate cancer.
about
Leupaxin, a novel coactivator of the androgen receptor, is expressed in prostate cancer and plays a role in adhesion and invasion of prostate carcinoma cellsPurification and identification of a novel complex which is involved in androgen receptor-dependent transcriptionSENP1 enhances androgen receptor-dependent transcription through desumoylation of histone deacetylase 1Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle interventionProstate cancer stem cellsHuman PIRH2 enhances androgen receptor signaling through inhibition of histone deacetylase 1 and is overexpressed in prostate cancerThe roles of sex steroid receptor coregulators in cancerSignal transducer and activator of transcription 5A/B in prostate and breast cancersDifferential effects of genistein on prostate cancer cells depend on mutational status of the androgen receptorDistinct nuclear and cytoplasmic functions of androgen receptor cofactor p44 and association with androgen-independent prostate cancerCharacterization of the Six1 homeobox gene in normal mammary gland morphogenesis.Tumor suppressor function of androgen receptor coactivator ARA70alpha in prostate cancer.Analysis of the 10q11 cancer risk locus implicates MSMB and NCOA4 in human prostate tumorigenesisRegulation of androgen-responsive transcription by the chromatin remodeling factor CHD8.Redefining hormone resistance in prostate cancer.Mediator and human diseaseART-27, an androgen receptor coactivator regulated in prostate development and cancer.Selective blockade of androgenic steroid synthesis by novel lyase inhibitors as a therapeutic strategy for treating metastatic prostate cancer.Hic-5, an adaptor-like nuclear receptor coactivator.Transcription factor Stat5a/b as a therapeutic target protein for prostate cancer.PIAS1 is a crucial factor for prostate cancer cell survival and a valid target in docetaxel resistant cellsAndrogen receptor signaling in prostate cancer development and progression.The androgen receptor directly targets the cellular Fas/FasL-associated death domain protein-like inhibitory protein gene to promote the androgen-independent growth of prostate cancer cells.Identification of novel androgen receptor target genes in prostate cancer.Differentially Expressed Genes and Signature Pathways of Human Prostate Cancer.Steroid hormone receptor signaling in tumorigenesis.Prostate epithelial stem cells.Stimulation of prostate cancer cellular proliferation and invasion by the androgen receptor co-activator ARA70Expression and function of nuclear receptor co-activator 4: evidence of a potential role independent of co-activator activity.Investigation of the relationship between prostate cancer and MSMB and NCOA4 genetic variants and protein expression.Cancer stem cells in prostate adenocarcinoma: a target for new anticancer strategies.Androgen receptor coactivator p44/Mep50 in breast cancer growth and invasion.Soy isoflavones and prostate cancer: a review of molecular mechanisms.The role of intracrine androgen metabolism, androgen receptor and apoptosis in the survival and recurrence of prostate cancer during androgen deprivation therapy.Cancer nanomedicines targeting tumor extracellular pH.Central role of RET in thyroid cancer.Thyroid Cancer: Role of RET and Beyond.Genome-wide analysis of androgen receptor binding and gene regulation in two CWR22-derived prostate cancer cell lines.Steroid Hormone Receptor Coregulators in Endocrine Cancers.SUMO ligase PIAS1 functions as a target gene selective androgen receptor coregulator on prostate cancer cell chromatin.
P2860
Q24308733-49960A9E-A675-43F1-A8A8-1A7B6B974E82Q24322855-7621854C-18A1-4992-B3D6-4F570E4869E6Q24563640-866DE09F-732C-4721-BAEB-34A51D7DEF1DQ24653994-349B80BD-FA81-4469-B061-113BF916AB73Q24654712-91F7A950-5F16-4102-BF8E-D34B53595E33Q24670460-96022F16-9CCF-49B1-9CD6-5B5FA04CAFE6Q24799904-69EF666A-6176-45BC-BFC4-EC70A959956AQ28281791-3A3E9D50-B287-4225-8D39-04C5EF29670BQ28534575-8C5E6B27-F5CD-4E0A-94A0-7A5BF37B1FAAQ28593215-20B605EC-0730-475B-BFA1-42CE1E9749BFQ33523907-9CB5FE72-65B3-415D-B626-D105FD1AD277Q33745234-A5F02315-D905-4D23-92EC-FC63D65BD982Q33750087-4DD5EDC3-587D-4416-ACFC-5076A5E0AFAEQ33874370-1F5D17CA-3A27-41B4-B7DB-78A0DF1FC10AQ33903836-08B88A26-6EDD-40C9-BCC8-ED0F41920805Q33909044-D7F2F45A-6080-44CD-9202-C793C3D588EEQ34288622-0CDBE154-C558-4116-96B1-34426110AD54Q34467551-E6A31075-E089-418F-BD7F-9C4EBC34031DQ34803398-5AD7BECB-0EF2-4B10-B1EA-59971FE304E2Q35012937-4D1D76AD-A32E-4B3F-B30D-4FAAE9AB96FCQ35068026-96FD1CD7-0472-41AF-A2C8-472215E040E8Q35183663-064682CA-68AB-4887-BAA0-D9B3D4650F5BQ35758327-FDC98AD3-298B-4B57-980D-8D213B6E14BDQ35865261-294EE007-98F1-41A7-BE88-989DF083EB6CQ35873154-A1862D3B-2604-4E60-89E3-06BA6A42EE20Q36224260-157388BC-E695-410B-BF13-6364E5BC0E57Q36318592-1D4C068C-1C68-48CB-A18B-94F2E8B72EB0Q36357367-6BE02F0C-CCD6-4544-BAAD-F74A3BF72974Q36382025-AE10A4D3-0561-40D1-9F81-6437CCC8CC89Q36496051-36F238A0-AA90-4E54-9073-AA81C817FB9BQ37164173-EF5F56B6-6D3D-46A5-97DF-2FA18D4D4B08Q37294322-9419AF96-9C81-42EC-BCF1-5295B74933C9Q37654590-978526A3-34C6-4290-B367-E657986DB31CQ37709925-767073AB-75F5-45C9-92BF-D0681AF495FEQ37955451-636B0F81-7F81-415E-B53C-51ACFC4FEFA9Q38167995-8A83B58F-A03F-4819-BEFA-758385B4AC40Q38208316-E5FE74B7-8B9F-46FB-A42A-31EBE61396AAQ38342443-8CEE3E2A-ECFC-47AC-9FAA-0D4D2AA7BBB4Q38848340-44CF301E-7361-45FB-A1F7-C84130893AE4Q38924091-A5FD199D-3035-48EE-930E-F7762E4457ED
P2860
Heterogeneous expression and functions of androgen receptor co-factors in primary prostate cancer.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Heterogeneous expression and f ...... rs in primary prostate cancer.
@en
type
label
Heterogeneous expression and f ...... rs in primary prostate cancer.
@en
prefLabel
Heterogeneous expression and f ...... rs in primary prostate cancer.
@en
P2093
P2860
P1476
Heterogeneous expression and f ...... rs in primary prostate cancer.
@en
P2093
Robert G Roeder
Zhengxin Wang
P2860
P304
P356
10.1016/S0002-9440(10)64422-7
P407
P577
2002-10-01T00:00:00Z